{"url_path":"/sec/ach/8-k/2026-05-15/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 ****Submission of Matters to a Vote of Security Holders.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/75252/0001104659-26-061888-index.html","accession_number":"0001104659-26-061888","cik":"0000075252","ticker":"ACH","issuer_name":"ACCENDRA HEALTH INC/VA/","edgar_url":"https://www.sec.gov/Archives/edgar/data/75252/0001104659-26-061888-index.html","primary_entity_key":"0000075252","primary_entity_name":"ACCENDRA HEALTH INC/VA/"},"word_count":293,"has_tables":true,"body_markdown":"**Item 5.07****Submission of Matters to a Vote of Security Holders.**\n\nOn May 14, 2026 at the 2026 Annual Meeting of Shareholders of the Company, the matters described below were voted upon and approved as indicated. There were 76,437,917 shares of common stock entitled to vote at the meeting and 62,134,133 shares were voted in person or by proxy (approximately 81.29% of shares entitled to vote).\n\n(1)Election of six directors, each for a one-year term, as follows:\n\n​\n\n**Votes**\n\n​\n\n**Director**\n\n**Votes****For**\n\n**Votes********Against**\n\n**Abstentions**\n\n**Broker******\n\n**Non-****Votes**\n\nMark A. Beck\n\n50,962,576\n\n1,294,183\n\n113,704\n\n9,763,670\n\nGwendolyn M. Bingham\n\n51,120,827\n\n1,136,584\n\n113,052\n\n9,763,670\n\nKenneth Gardner-Smith\n\n50,944,000\n\n1,312,205\n\n114,258\n\n9,763,670\n\nStephen W. Klemash\n\n51,165,959\n\n1,090,992\n\n113,512\n\n9,763,670\n\nTeresa L. Kline\n\n51,189,677\n\n1,068,135\n\n112,651\n\n9,763,670\n\nEdward A. Pesicka\n\n48,760,777\n\n3,497,266\n\n112,420\n\n9,763,670\n\n​\n\n(2)Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 as follows:\n\n​\n\n**Votes**\n\n**Votes****For**\n\n**Votes********Against**\n\n**Abstentions**\n\n**Broker******\n\n**Non-****Votes**\n\n61,255,312\n\n693,111\n\n185,710\n\n-\n\n​\n\n​\n\n(3)Non-binding advisory vote to approve the compensation of our named executive officers as follows:\n\n​\n\n**Votes**\n\n**Votes****For**\n\n**Votes********Against**\n\n**Abstentions**\n\n**Broker******\n\n**Non-****Votes**\n\n48,137,834\n\n4,098,288\n\n134,341\n\n9,763,670\n\n​\n\n(4)Approval of the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan as follows:\n\n​\n\n**Votes**\n\n**Votes****For**\n\n**Votes********Against**\n\n**Abstentions**\n\n**Broker******\n\n**Non-****Votes**\n\n50,645,557\n\n1,573,141\n\n151,765\n\n9,763,670\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**SIGNATURE**\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n**ACCENDRA HEALTH, INC.**\n\n​\n\n​\n\nDate: May 15, 2026\n\nBy:\n\n/s/ Heath H. Galloway\n\n​\n\nName:\n\n ​\n\nHeath H. Galloway\n\n​\n\nTitle:\n\n​\n\nExecutive Vice President, General Counsel and Corporate Secretary\n\n​\n\n​\n\n​\n\n​"}